Small Cap Feast

13th June 2024

Dish of the day
No Joiners today
Off the menu
No leavers today


Dish Of The Day:


Admissions: 


Delistings: 





Whats baking in the oven?

Potential**** Initial Public Offerings:

ITF announced:

22nd May: Following the confirmation of the ITF, Raspberry Pi  announces the successful pricing of its IPO at 280 pence per Ordinary Share on 11 June. It is due to start trading on 14 June. Based on the Offer Price, Raspberry Pi's market capitalisation will be approximately £541.6m at the commencement of conditional dealings on the Main Market of the London Stock Exchange.  Raspberry Pi is a designer and developer of high-performance, low-cost single board computers and compute modules for industrial IoT customers and embedded uses, as well as for enthusiasts and educators, in markets worldwide. The Group's revenue was $140.6m, $187.9m and $265.8m and gross profit was $41.9m, $42.3m and $66.0m in the years ended 31 December 2021, 2022, and 2023, respectively.

4th June: Advanced Oxygen Therapy Inc (AOTI): The medical technology group with a proprietary therapy for the reduction in hospitalisations and amputations caused by non-healing wounds, particularly diabetic foot ulcers, announces its Schedule One and expected first day of trading on the AIM market of the 18th June. The Group expects to raise $25m.

Media speculation: (We remove rumours after 10 days of being on the menu)


Reverse Takeovers:


Change of Market:

Dual Listing :


Banquet Buffet

Acuity RM Group 4.2p £4.86m (ACRM.L)

The established provider of risk management services announces its final results for the year ended 31 December 2023. There was an 88% growth in sales pipeline, up to £7.9m (£4.2m 2023). The Company had cash balances of £787,110 and current debt of £353,845. Forward contracted revenue was £2.9m (£2.2m 2023) with 34% growth. The Company is committed to winning new contracts in the high-growth market with key customers and forging relationship with partners to accelerate the growth.

Coro Energy* “suspended”

Yesterday afternoon, the South East Asian energy Company with a natural gas and clean energy portfolio released an update regarding the disposal of the Group's Italian natural gas portfolio. The Company announces an acceleration of receipt of a portion of the proceeds from the disposal of the Group's Italian natural gas portfolio. The Company sold its Italian natural gas portfolio as previously announced by the Company during the course of 2023 and 2024 (the Disposal).  The Disposal includes a monthly payment to the company of Euro 42,750 through to November 2025 and a final payment of Euro 26,750 in December 2025.  All monthly payments have been received to-date. The Company has today signed an agreement to accelerate the next 9 months payment in exchange for a 22% discount on those payments.  Hence the Company will now receive Euro 150,000 on June 14 2024 and a further Euro 150,000 thirty days later. The monthly payments will restart from April 2025.

Kibo Energy* 0.03p £0.05m (KIBO.L)

The renewable energy-focused development Company today announces an update to its corporate restructuring and re-positioning announcement of 7 June 2024. The Company has carried out a thorough review upon the strategic decision (including board changes) made in the previous announcement. As a result, the proposed Placing of £500,000 at 0.015 pence will not proceed as expected. The Company decided not to implement all the board changes as announced and is working to agree the management team in line with the Kibo recovery strategy and plan in terms of the team’s experience and expertise to deliver the deliver the transition of Kibo to be a broader energy company.

Libertine Holdings  2.0p 2.44m (LIB.L)

The developer of Linear Generator technology provides an update regarding the Strategic Review and Formal Sale Process announced on 29 April 2024. The Company has received an indicative, non-binding, conditional investment offer from potential strategic investors based in India and the United Arab Emirates of £2.0m at 2.1 pence per ordinary share in the Company. The Proposed Investment based on the terms currently presented could bring the strategic investors’ holdings up to 41% of the enlarged issued share capital of the company in total. In the absence of further developments by mid-June 2024, the Board may seek cancellation of Admission of the Company's ordinary shares to trading on AIM and re-registration as a private limited company.

NWF Group 200p £94.2m (NWF.L)

The specialist distributor operating in UK markets today provides a trading update for the financial year ended 31 May 2024. Benefitting from increased commercial customer orders due to mild weather, the volume of fuel distribution in FY24 remained ahead of the prior year. Trade in the food market in FY24 remains ahead of the prior year as well with strong customer pipeline. And trade in feeds in FY24 was weaker compared to the prior year. Net cash at the year-end of £10m is in line with market expectations. The strong financial position would further support the Group’s strategic acquisition in Fuels

Orcadian Energy 10p £7.5m (ORCA.L)

The Company focuses on low emissions, oil and gas exploration and development in the North Sea today announces the update following the previous announcement on 22 May. The Company has entered into a secured long-term loan with an industry partner who has agreed to loan Orcadian up to £1,150,000 for two years. The Interest is supposed to accrue from the drawdown date to the date the loan is repaid in full rate. The rate will be determined at drawdown and is expected to be between 6% and 9%. The drawdown is expected to be provided before 30 June 2024. The loan is made to enable Orcadian to repay the outstanding loan to Shell International Trading and Shipping Company Limited and Orcadian would provide the Partner with a security over its 18.75% interest in the Pilot filed.

Petards Group* 7.5p £4.6m (PEG.L)

The developer of advanced security and surveillance systems announces its audited final results for the year ended 31 December 2023. Revenue was £9,424,000 (2022: £10,872,000) and the loss after tax was £1,050,000 (2022: £524,000 profit). The current net funds was £1,241,000 (31 Dec 2022: £1,891,000). The Group also announces that it has today reached a conditional agreement to acquire Affini Technology Group Limited and thereby indirectly its wholly owned subsidiary, Affini Technology Limited. Affini is a UK based critical communications solutions provider to the transport, blue light, energy, defence and construction sectors. The consideration of the acquisition will be approximately £2.8m comprising a payment for adjusted net assets of £1.5m, and a payment for goodwill of £1.3m. The consideration will be satisfied by a £2.5m cash payment and the issue of 4,176,810 new ordinary shares with an aggregate value of £326,000. The Board believes that the actions it has put in place and its continued focus on costs and gross profit margin performance should help to mitigate the impact on the adjusted EBITDA for the year. The Acquisition will increase the Group’s recurring revenues with approximately 50% of Affini’s £5.6m revenue for the financial year ended 31 December 2023 relating to managed services and maintenance.

Physiomics * 1.5p £1.8m (PYC.L)

The leading mathematical modelling and data science Company supporting the development of new therapeutics and personalised medicine solutions announces that it has been awarded a new contract by an existing, large client. The project includes using the Company’s proprietary Virtual Tumour platform to model the client's targeted oncology agents in combination with other modalities to help inform dose and scheduling decisions. The value of the contract is £186k and it is expected to be completed over the current year. The Company will be stepping into the next financial year ending 30 June 2025, during which the revenue is committed to be over £0.5m.

Tracsis 810p £271.4m (TRCS.L)

The leading transport technology provider provides the trading update for the year ending 31 July 2024. The Board now expects FY24 revenue to fall in the range of £80.0m – £82.0m, and the adjusted EBITDA margin is estimated to be a bit higher than 15.5% in H1 2024, but below the analyst consensus market expectations. And the Company’s financial position still remains robust with net cash of £15.5m on 31 May 2024. The expectation of adjusted EBITDA and revenue is still expected to be unchanged. Tracsis has confidence that the prospect in FY25 would not be negatively affected by the change in the political environment in the UK or US and the Board's progressive dividend policy will remain unaffected.

Trident Royalties 48.2p £117.2m (TRR.L)

The diversified mining royalty and streaming Company announces that it has reached agreement on the terms and conditions of a recommended all-cash offer by Deterra Global Holdings Pty Ltd for the entire issued and to be issued share capital of Trident. Each Trident shareholder will be entitled to receive 49 pence in cash for each Trident share. The entire issued and to be issued share capital of Trident would have the value of £144m in total. The Company recommends that it be acquired due the recognition of the potential risks associated with unlocking value as an independent business as well as the desire for a liquidity event to minimise the effect of the illiquid nature of the share of Trident.

.

13 June 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram